GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Myrexis Inc (FRA:R9M) » Definitions » ROCE %

Myrexis (FRA:R9M) ROCE % : -48.89% (As of Jun. 2013)


View and export this data going back to . Start your Free Trial

What is Myrexis ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Myrexis's annualized ROCE % for the quarter that ended in Jun. 2013 was -48.89%.


Myrexis ROCE % Historical Data

The historical data trend for Myrexis's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myrexis ROCE % Chart

Myrexis Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13
ROCE %
Get a 7-Day Free Trial -72.06 -30.56 -27.46 -33.11 -25.21

Myrexis Quarterly Data
Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.06 -16.98 -22.83 -31.15 -48.89

Myrexis ROCE % Calculation

Myrexis's annualized ROCE % for the fiscal year that ended in Jun. 2013 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2013 )  (A: Jun. 2012 )(A: Jun. 2013 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2013 )  (A: Jun. 2012 )(A: Jun. 2013 )
=-9.089/( ( (73.046 - 1.816) + (0.938 - 0.056) )/ 2 )
=-9.089/( (71.23+0.882)/ 2 )
=-9.089/36.056
=-25.21 %

Myrexis's ROCE % of for the quarter that ended in Jun. 2013 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2013 )  (Q: Mar. 2013 )(Q: Jun. 2013 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2013 )  (Q: Mar. 2013 )(Q: Jun. 2013 )
=-0.464/( ( (1.282 - 0.266) + (0.938 - 0.056) )/ 2 )
=-0.464/( ( 1.016 + 0.882 )/ 2 )
=-0.464/0.949
=-48.89 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2013) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Myrexis  (FRA:R9M) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Myrexis ROCE % Related Terms

Thank you for viewing the detailed overview of Myrexis's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Myrexis Business Description

Traded in Other Exchanges
N/A
Address
630 Fifth Avenue, Suite 2260, New York, NY, USA, 10020
Myrexis Inc is engaged in evaluating strategic alternatives, such as identifying, evaluating and making financial investments in life sciences assets.

Myrexis Headlines

No Headlines